{
    "nct_id": "NCT01489813",
    "official_title": "Phase II Randomized Placebo-Controlled Clinical Trial of Genistein in Reducing the Toxicity and Improving the Efficacy of Intravesical Therapy",
    "inclusion_criteria": "1. Male or female gender\n2. 18 years or older\n3. Diagnosis of superficial bladder cancer\n4. Scheduled for induction BCG intravesical therapy\n5. Willing and able to give blood sample\n6. Willing and able to fill out a pill diary to ensure compliance\n7. Willing and able to sign informed consent\n8. Birth control is not required for this study!\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Patients who are pregnant\n2. Diagnosis of muscle-invasive bladder cancer\n3. Unwillingness to follow study protocol and compliance procedures\n4. HIV positive or immunocompromised\n5. Receiving concurrent immunotherapy or chemotherapy\n6. Presence of concurrent second cancer (active, not history)",
    "miscellaneous_criteria": ""
}